Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PRKCBP1 protein, human

Known as: Cutaneous T-Cell Lymphoma-Associated Antigen se14-3, Zinc Finger MYND Domain Containing Protein 8, CTCL Tumor Antigen se14-3 
Protein kinase C-binding protein 1 (1186 aa, ~132 kDa) is encoded by the human ZMYND8 gene. This protein plays a role in protein kinase C function… Expand
National Institutes of Health

Related topics

Related topics

11 relations
BromodomainCell NucleusGenes, RegulatorMetal Ion Binding
Expand

Broader (1)

receptors for activated C kinase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Protein kinase C binding protein 1 inhibits hypoxia-inducible factor-1 in the heart.
AIMS Hypoxia-inducible factor-1 alpha (HIF-1α) is a key transcription factor responsible for the induction of genes that… Expand
Review
2017
Review
2017
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK…
Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma… Expand
2015
2015
Therapeutische Erfahrungen mit der Extrakorporalen Photopherese Technisches Vorgehen, Überwachung und klinische Ergebnisse bei 41 Hautkranken
ZusammenfassungDie Extrakorporale Photopherese (ECP) stellt ein seit fast 10 Jahren geübtes und inzwischen erprobtes… Expand
2012
2012
Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma
Angiogenin is a member of the ribonuclease superfamily that is associated with the angiogenic process. Angiogenesis is regarded… Expand
  • figure 1
  • figure 2
  • figure 3
2012
2012
Analisi molecolare dei linfomi cutanei aggressivi
I linfomi primitivi cutanei riconosciuti nella classificazione della WHO/EORTC si presentano come “entita cliniche distinte” su… Expand
2012
2012
Apoptoseresistenz beim kutanen T-Zell-Lymphom
Kutane Lymphome sind langsam wachsende, maligne Tumoren, deren klinischer Verlauf auf eine Apoptoseresistenz hindeutet. In… Expand
2004
2004
Identification of FHOD1‐binding proteins and mechanisms of FHOD1‐regulated actin dynamics
Formin homology‐2‐domain containing protein 1 (FHOD1) regulates gene transcription, actin‐cytoskeleton structure, and cell… Expand
2003
2003
Extracorporeal Photopheresis and Multimodality Immunomodulatory Therapy in the Treatment of Cutaneous T-Cell Lymphoma
The use of photochemotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) was first reported by Gilchrest et al. in 1976… Expand
Review
1996
Review
1996
Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients.
BACKGROUND Most patients with erythrodermic cutaneous T-cell lymphoma (CTCL) have intense, generalized, refractory pruritus. In… Expand
Review
1994
Review
1994
Coexistent cutaneous T-cell lymphoma and B-cell malignancy. French Study Group on Cutaneous Lymphomas.
BACKGROUND The coexistence of cutaneous T-cell lymphoma (CTCL) and a B-cell malignancy (BCM) is rare. OBJECTIVE Our aim was to… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE